Biosplice Therapeutics is in the medical research and development for tissue-level regeneration. With their platform's origins in small molecule-based Wnt pathway modulation, they develop therapeutics to address a range of degenerative diseases, regenerative medicine, and oncology.Samumed adopted a fresh operating philosophy from thebeginning — one based on a goal of building a broad technology platform aimed at modulating regenerative pathways to improve patient health.

Biotechnology

Health Care

Biosplice Therapeutics

Cevdet Samikoglu

Mirta Grifman

SAM NAMIQ

Scott Bulcao

Osman Kibar

John Hill

Erich Horsley

Christopher Swearingen

The Research and Development team at Biosplice Therapeutics focuses on advancing the company's core platform of small molecule-based Wnt pathway modulation. They innovate and develop new therapeutics for addressing degenerative diseases, regenerative medicine, and oncology. The team's responsibilities include biological research, compound management, medicinal chemistry, and discovering novel therapeutic targets to improve patient outcomes.

Research and Development

Leadership Team

Clinical Operations

Research and Development

About

Team members

Other teams at Biosplice Therapeutics

Leadership Team

Clinical Operations